| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 18, 2013
Perrigo Company plc (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc ("Elan") today announced that Perrigo has completed the acquisition of Elan in a...
-
Dec 13, 2013
Perrigo Company (NYSE: PRGO; TASE) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced that the Irish High Court has approved...
-
Nov 21, 2013
Perrigo Company (NYSE, TASE: PRGO) today announced that, in connection with its offer to purchase for cash (the "Tender Offer") any and all of its...
-
Nov 20, 2013
Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application...
-
Nov 18, 2013
Perrigo Company (NYSE: PRGO; TASE), a leading global healthcare supplier ("Perrigo") today announced that, at a shareholder meeting held today,...
-
Nov 6, 2013
Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on December...
-
Nov 1, 2013
The Perrigo Company (NYSE: PRGO; TASE) announced today that it has initiated a voluntary, nationwide product recall to the retail level of 18 batches...
-
Oct 31, 2013-- Fiscal first quarter net sales of $933 million, up 21%.
Perrigo Company (NYSE: PRGO; TASE) today announced results for its first quarter ended September 28, 2013. (Logo: ...
-
Oct 24, 2013
In the news release, Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013, issued Oct. 24, 2013 by Perrigo Company over PR Newswire, we are advised by the company...
-
Oct 9, 2013
Perrigo Company (NYSE, TASE: PRGO) today announced that it has scheduled a shareholder meeting for Monday, November 18, 2013 in connection with...